Clik here to view.
Biodesix® and Bioyong Announce Agreement for Joint Development and...
BOULDER, Colo. Biodesix, Inc. and Bioyong Technology Company Ltd. (Beijing, China) announced today that they have entered into an international collaboration agreement where Bioyong will develop and...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Limited to Present at the J.P. Morgan 35th Annual...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced that the Company will present at the J.P. Morgan 35th Annual Healthcare...
View ArticleClik here to view.
Kite Pharma Establishes a Strategic Partnership With Daiichi Sankyo to...
SANTA MONICA, Calif. Kite Pharma (Nasdaq:KITE) announced today that it has entered into a strategic partnership with Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) for axicabtagene ciloleucel (approved...
View ArticleClik here to view.
PerkinElmer to Acquire Tulip Diagnostics Private Limited in India
WALTHAM, Mass. PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it has entered into a definitive agreement to acquire Tulip...
View ArticleClik here to view.
PerkinElmer to Acquire Tulip Diagnostics Private Limited in India
GOA, India PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has entered into a definitive agreement to acquire Tulip Diagnostics Private Ltd....
View ArticleClik here to view.
First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® system
LONDON BTG plc (LSE: BTG), the global specialist healthcare company, today announced the first patients diagnosed with Pulmonary Embolism (PE) to be treated in Hong Kong using the newly available...
View ArticleClik here to view.
武田与PvP Biologics宣布开发乳糜泻治疗新药的协议
日本大阪和圣迭戈和西雅图 (美国商业资讯) — 武田药品工业株式会社（“武田”）(TOKYO:4502)与PvP Biologics, Inc. (“PvP”)今天宣布签署一份开发新型酶KumaMax的全球性协议，该酶旨在于胃中降解麸质中引起免疫反应的部分，从而避免意外摄入麸质所致的疼痛症状和对小肠造成的损伤。 Smart News...
View ArticleClik here to view.
Kite Pharma and Fosun Pharma Establish Joint Venture in China to Develop and...
SANTA MONICA, Calif. & SHANGHAI Kite Pharma (Nasdaq:KITE) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) (600196.SH,02196.HK), today announced a joint venture, Fosun Pharma...
View ArticleClik here to view.
LFB S.A.、血液凝固第VIIa因子組み換え製剤（活性型エプタコグベータ）に関し提出済みの生物学的製剤承認申請を米食品医薬品局（FDA）が受理したと本日発表
仏レジュリス （ビジネスワイヤ） — LFB...
View ArticleClik here to view.
Pharmaron Acquires Xceleron Inc.
BEIJING Pharmaron, a fully integrated contract research organization offering R&D services for the life science industry, today announced the acquisition of Xceleron Inc. Xceleron is a Maryland,...
View ArticleClik here to view.
POC Medical Systems™ Raises $21 Million in Series A Funding to Advance Rapid,...
LIVERMORE, Calif. POC Medical Systems™ Inc. announced today that it raised $ 21 million in Series A funding for clinical beta testing and initial commercialization of a rapid, portable breast cancer...
View ArticleClik here to view.
Seqirus and Zambon Enter into a Partnership for Parkinson’s Disease Product...
MILAN Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS)...
View ArticleClik here to view.
Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance...
BRISBANE, Calif. & CAMBRIDGE, Mass. & OSAKA, Japan Maverick Therapeutics Inc., an MPM Capital portfolio company, and Takeda Pharmaceutical Company Limited (TSE:4502) announced today that...
View ArticleClik here to view.
GI Dynamics, Inc. Provides 2017 Business Outlook and 2016 Review
BOSTON & SYDNEY GI Dynamics, Inc., (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe for patients with type 2 diabetes and obesity, today released a 2017...
View ArticleClik here to view.
VivaGel® BV granted QIDP and Fast Track designation by US FDA
MELBOURNE, Australia Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) today announced it has been granted Qualified Infectious Disease Product (QIDP) and Fast Track designation for VivaGel® BV by the...
View ArticleClik here to view.
Orthocell Announces Collaboration with Johnson & Johnson Innovation
PERTH, Australia Regenerative medicine company Orthocell Limited has today announced a research collaboration agreement with DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of...
View ArticleClik here to view.
艾培拉科学公司（Apira Science，Inc.）警告中国消费者有关未经授权网上销售iGrow生发系列的事宜
BOCA RATON, Fla. (美国商业资讯)–艾培拉科学公司（Apira Science，Inc.）警告中国消费者立即停止购买淘宝网（阿里巴巴集团创立的中国网上商场）上未经授权第三方经销商和其它电子商务网站出售的iGrow 生发系列（“iGrow”）。...
View ArticleClik here to view.
Apira Science Warns Chinese Consumers About Unauthorized Online Sales of the...
BOCA RATON, Fla. Apira Science, Inc. is warning Chinese consumers to immediately avoid purchasing the iGrow Hair Growth System (the “iGrow”) units that have been listed by unauthorized third-party...
View ArticleClik here to view.
Tocagen Expands Toca 5, Phase 2/3 Clinical Trial for Recurrent Brain Cancer,...
SAN DIEGO Tocagen Inc., a clinical-stage, cancer-selective gene therapy company, today announced its randomized, controlled Phase 2/3 clinical trial, called Toca 5, is now enrolling patients in...
View ArticleClik here to view.
Chi-Med Initiates a Phase II Combination Study of Fruquintinib with Iressa®...
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that it has initiated a Phase II study of a combination therapy using fruquintinib and Iressa® in the first-line...
View Article